Super-K Flu: What New Zealand Needs to Know About the Evolving Threat
New Zealand is bracing for a potentially challenging winter flu season with the arrival of H3N2 Subclade K, dubbed the ‘Super-K’ flu. This variant, which spread through the US and Europe last year, is already present in Australia and demonstrating a faster rate of transmission than typical seasonal influenza.
Understanding the Super-K Strain
The ‘Super-K’ flu isn’t a completely new virus; it’s a seasonal influenza strain that has undergone significant mutations, particularly in its Hemaglutinin protein. These changes affect how the virus spreads and interacts with the immune system. According to the CSIRO, Australia’s national science agency, the virus is spreading earlier than usual.
Vaccine Effectiveness and Current Protections
While not appearing more severe than previous flu strains, Super-K presents a challenge to vaccine effectiveness. Professor Peter McIntyre of Otago University notes the strain is less well-matched to the current vaccine. However, New Zealand may be in a better position than the northern hemisphere, as vaccine formulation for this year included a similar strain.
The Changing Landscape of Respiratory Viruses
The predictability of flu seasons has diminished since the COVID-19 pandemic. The typical winter peak is becoming less defined, with increased unpredictability in virus circulation patterns. This shift necessitates ongoing monitoring and adaptation of public health strategies.
Who is Most at Risk?
Individuals over the age of 65, and especially those over 75 or 80, are considered at higher risk of complications from the flu and are strongly advised to get vaccinated as early as possible. Those in residential aged care facilities are particularly vulnerable.
Exploring Enhanced Vaccine Options
The Fluad vaccine offers potentially greater protection, but It’s currently not publicly funded in New Zealand. Immunisation advisory centres are advocating for funding, particularly for vulnerable populations.
Frequently Asked Questions
What is the Super-K flu?
Super-K is a subtype of the H3N2 influenza virus that has undergone mutations, causing it to spread more rapidly than typical seasonal flu.
Is the flu vaccine effective against Super-K?
The current vaccine is less well-matched to Super-K, but still offers some protection and can reduce the severity of illness.
Who should get vaccinated?
Anyone over the age of 65, and those with underlying health conditions, are strongly encouraged to get vaccinated.
Is the Fluad vaccine available in New Zealand?
The Fluad vaccine is not currently publicly funded in New Zealand, but is available privately.
Sign up for Ngā Pitopito Kōrero, a daily newsletter curated by our editors and delivered straight to your inbox every weekday.
Stay informed and protect yourself this flu season. Share this article with your friends and family, and discuss vaccination options with your healthcare provider.
Worth a look